RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 September 2011 | By Michael Matthews 

Recently, two pilot programs were completed by the European Medicines Agency (EMA), the US Food and Drug Administration (FDA) and Australian Therapeutic Goods Administration (TGA) to increase international collaboration on drug quality and safety. The two pilot programs included inspections on active pharmaceutical ingredient (API) manufacturers' and Good Clinical Practice (GCP) compliance. On 2 August 2011, EMA published a press release summarizing the results of these two programs.

 

© 2022 Regulatory Affairs Professionals Society.